20642 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs; Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
Methods for inducing hematopoietic stem cell specificity
#302Modified pluripotent cells
#303PRODUCTION METHOD FOR IPS CELL-DERIVED POPULATION OF GENETICALLY DIVERSE T CELLS
#304Stem cell subpopulations with differential GSTT1 expression or genotype
#305Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#306Composition for improving, preventing or treating skin diseases comprising induced pluripotent stem cell-derived mesenchymal stem cell and exosome derived therefrom
#307STEM CELL COMPOSITIONS FOR COSMETIC AND DERMATOLOGIC USE
#308Gene and cell therapy using cell fusion technology
#309Compositions and methods for treating and preventing tissue injury and disease
#310Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#311Method of Treating Focal Segmental Glomerulosclerosis
#312REPROGRAMMING OF A DIFFERENTIATED CELL TO AN UNDIFFERENTIATED CELL USING EXOSOME
#313Treatment of immune disorders
#314Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue
#315Tagged chimeric effector molecules and receptors thereof
#316Hydrogel for stem cell and organoid culture
#317Human pluripotent stem cell derived endocardial endothelium
#318Methods for inducing partial apoptosis using caspase polypeptides
#319Method to improve therapeutic properties of stem cells
#320METHODS AND SYSTEMS FOR RECONSTRUCTION OF DEVELOPMENTAL LANDSCAPES BY OPTIMAL TRANSPORT ANALYSIS
#321Method for producing photoreceptor cells, retinal pigmented epithelial cells, and retinal organoids
#322USE OF DES-ASPARTATE-ANGIOTENSIN I TO TREAT PATIENTS EXHIBITING INFLAMMATORY DISEASES AND THEIR SYMPTOMS
#323STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS
#324AMELIORATION AND TREATMENT OF BRAIN DISORDER RESULTING FROM FETAL GROWTH RETARDATION USING PLURIPOTENT STEM CELLS
#325METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC
#326METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERM CELLS
#327Compounds that enhance Atoh1 expression
#328METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#329Cranial access device
#330CRYOPRESERVATION
#331Bioengineered allogeneic blood vessel
#332PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION
#333Gene correction of Pompe disease and other autosomal recessive disorders via RNA-guided nucleases
#334Dual Therapy Device and Related Method
#335TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT IN SEXUAL QUALITY OF LIFE
#336Antigen-specific immune effector cells
#337EXTRACELLULAR VESICLES FROM STEM CELLS TO TREAT AND/OR PREVENT DISEASE
#338Methods and compositions for treatment of penile defects
#339Corneal endothelial cell marker and use thereof
#340METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
#341Cells and Methods of Uses and Making the Same
#342METHODS FOR MEASURING THERAPEUTIC EFFECTS OF RETINAL DISEASE THERAPIES
#343Methods and compositions for enhancing cardiomyocyte maturation and engraftment
#344Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury
#345METHODS FOR MAKING AND USING DEDIFFERENTIATED AND STEM-LIKE HUMAN CELLS
#346Methods of treating systemic graft-versus-host disease with extracellular vesicles
#347HLA-INDEXED REPOSITORY OF iPSCS AND iPSC-DERIVED STEM CELLS, AND RELATED SYSTEMS AND METHODS
#348COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES WHICH HAS EXCELLENT BONE REGENERATION EFFECT
#349IL-12 IMMUNOTHERAPY FOR CANCER
#350METHODS FOR INDUCING SELECTIVE APOPTOSIS
#351CHEMICAL DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO RETINAL EPITHELIAL CELLS
#352Method for controlling differentiation of pluripotent stem cells
#353Crushed stem cell extract (shelled stem cell) manufacturing method using mass culture medium composition method and constituent 3-low extracting method and a treating composition for anti-inflammatory and a treating composition for cell regeneration
#354PANCREATIC PROGENITOR CELL PRODUCTION METHOD
#355Method of generating multi-lineage potential cells and multi-lineage potential cells produced therefrom
#356Compositions Comprising Human Embryonic Stem Cells and Their Derivatives, Methods of Use, and Methods of Preparation
#357METHODS OF GENERATING OLIGODENDROCYTES AND CELL POPULATIONS COMPRISING SAME
#358MATERIALS AND METHODS FOR TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA (DEB) AND OTHER COLLAGEN TYPE VII ALPHA 1 CHAIN (COL7A1) GENE RELATED CONDITIONS OR DISORDERS
#359HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses Thereof
#360ENCAPSULATED INTESTINAL MIDGUT ENDODERM CELLS
#361In vitro production of muscle stem cells
#362COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF
#363Methods of improving cell-based therapy
#364Neural cell extracellular vesicles
#365Human cell population comprising human retinal progenitor cells without an ISL1 gene for transplantation and methods of use thereof
#366METHOD OF PREPARING SOLUTION CONTAINING STEM CELLS
#367FROZEN THERAPEUTIC DOSE AND PACKAGE
#368Compositions for treatment of arthritis
#369Controllable transcription
#370MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE
#371Replicative transposon system
#372Development of amnion-like tissue from human pluripotent stem cells
#373PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS
#374Mammalian birth tissue composition for tumor treatment
#375Methods for promoting healing of tissue
#376Cryopreserved endocrine cells that express chromogranin A
#377Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
#378Methods for selective inhibition of pluripotent stem cells
#379AMELIORATION AND TREATMENT OF PERINATAL BRAIN DAMAGE WITH PLURIPOTENT STEM CELLS
#380PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS
#381WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
#382METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#383Methods of using ZSCAN4 for rejuvenating human cells
#384Methods for enhancing lifespan and/or treating cellular proliferative disorders by transplantation
#385IMPROVED METHODS FOR REPROGRAMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS
#386Compositions and methods for immune cell modulation in adoptive immunotherapies
#387Method for inducing pluripotent stem cells to differentiate into somatic cells
#388Tropic cell based virotherapy for the treatment of cancer
#389Compounds as inhibitors of sodium channels
#390NOVEL METHOD
#391Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
#392Modulators of syndecan-2 and uses thereof
#393Compositions and methods for inducing thrombopoiesis
#394Method for treating autoimmune disease using CD4 T-cells with engineered stabilization of expression of endogenous FOXP3 gene
#395METHODS AND COMPOSITIONS FOR POTENTIATING STEM CELL THERAPIES
#396Amelioration and treatment of chronic lung disease using pluripotent stem cells
#397METABOLIC DRUG LOADING OF EVs
#398METHODS OF DIFFERENTIATING STEM CELLS INTO ENDODERM
#399ALLEVIATION AND TREATMENT OF ISCHEMIA REPERFUSION-INDUCED LUNG INJURY USING PLURIPOTENT STEM CELLS
#400PROPHYLACTIC OR THERAPEUTIC AGENT FOR ORGAN FIBROSIS
#401PAR2 MODULATION TO ALTER MYELINATION
#402Pluripotent stem cell for treating diabetic skin ulcer
#403SINGLE GUIDE RNA/CRISPR/CAS9 SYSTEMS, AND METHODS OF USE THEREOF
#404Production of fully functional mature beta cells from human pancreatic progenitors
#405CELLS EXPRESSING PARATHYROID HORMONE 1 RECEPTOR AND USES THEREOF
#406Method of treating aortic aneurysm using muse cells
#407Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
#408Elimination of proliferating cells from stem cell-derived grafts
#409Compositions and methods for the depletion of CD117+ cells
#410Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
#411Conditioned stem cell-derived extract
#412Compositions and methods for the depletion of CD117+ cells
#413STEM CELLS FOR MODELING TYPE 2 DIABETES
#414Cellular Reprogramming Utilizing mRNA
#415ENHANCED GENE DELIVERY METHODS
#416Protein biomaterials and biocoacervates and methods of making and using thereof
#417Anti-Ryk antibodies and methods of using the same
#418Method and System for Repairing Damaged Tissue Using Nucleated Plasma Particles (Nuc-P2s) and Mesodermal Stem Cells (MesoSCs)
#419Customized hybrid bone-implant grafts
#420Topical Skin Care Compositions and Methods
#421SOMATIC STEM CELLS FOR TREATING BONE DEFECTS
#422Microfluidics device for fabrication of large, uniform, injectable hydrogel microparticles for cell encapsulation
#423Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
#424Methods for reprogramming cells and uses thereof
#425Compositions and methods for immunotherapy
#426Amniotic fluid composition and method of using
#427Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
#428Method and system for repairing damaged tissue using nucleated plasma particles (Nuc-P2s) and mesodermal stem cells (MesoSCs)
#429COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#430Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
#431LIGHT-ACTIVATED ANCHORING OF THERAPEUTIC FACTORS TO TISSUES
#432Isolation And Use Of Pluripotent Stem Cell Population From Adult Neural Crest-Derived Tissues
#433CAPILLARY VESSEL-DERIVED STEM CELLS, USE OF THE SAME, AND, METHOD FOR PRODUCING THE SAME
#434Methods and compositions for promoting thermogenic potential
#435Compositions and methods for modulating stem cells and uses thereof
#436Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy
#437Minimal volume reprogramming of mononuclear cells
#438REGENERATIVE MATERIALS
#439Genetically modified cells and uses thereof
#440ENHANCEMENT OF NUCLEUS PULPOSUS REGENERATION BY ENHANCED PERFUSION OF PERISPINAL AREA BY COMBINATION DRUG, GENE AND CELLULAR THERAPIES
#441Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases
#442USE OF NEURAL CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#443Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#444Neural cell extracellular vesicles
#445Composition for treatment of damaged part
#446Aerosilization of stem cells or stem cell derivatives for pulmonary delivery
#447Methods and compositions for inducing hematopoietic cell differentiation
#448Method for producing platelets using reciprocating stirring device
#449Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury
#450METHOD OF STEM CELL THERAPY
#451CELL-BASED TARGETED DELIVERY OF PSEUDONOMAS EXOTOXIN
#452Methods for improving cognition and slowing cognitive impairment using nonviable lyophilized pluripotent stem cells
#453MAPC treatment of brain injuries and diseases
#454Microvesicles derived from nucleated, mammalian cells and use thereof
#455METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC
#456DI-FUNCTIONALIZED HYALURONIC ACID DERIVATIVES AND HYDROGELS THEREOF
#457Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
#458PLACENTA-DERIVED CELLS EXCRETING C3 OR C1R COMPLEMENT AND COMPOSITION CONTAINING SAME
#459METHODS FOR INDUCING SELECTIVE APOPTOSIS
#460INDUCED PLURIPOTENT STEM CELL DERIVED GLIAL ENRICHED PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE
#461CELL CULTURE SUPERNATANT FLUID DERIVED FROM LUNG TISSUE
#462Method for producing retinal pigment epithelial cells
#463Modulation of splenocytes in cell therapy
#464METHOD FOR PRODUCING RETINAL TISSUE
#465Non-Invasive Methods for Assessing Genetic Integrity of Pluripotent Stem Cells
#466Methods for inducing selective apoptosis
#467Methods for inducing partial apoptosis using caspase polypeptides
#468METHOD OF STEM CELL-BASED ORGAN AND TISSUE GENERATION
#469Methods to differentiate stem cells into hormone-producing cells
#470Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems and methods
#471Three-dimensional vascular network assembly from induced pluripotent stem cells
#472Methods of improving cell-based therapy
#473Induced extended pluripotent stem cells, method of making and using
#474Gene and cell therapy using cell fusion technology
#475Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells
#476CELL LINES MUTANT FOR PATCHED 1 AND PATCHED 2 AND METHODS OF USE THEREOF
#477Compositions for Regenerating Defective or Absent Myocardium
#478Sulfated alginate hydrogels for cell culture and therapy
#479Method of making a population of chondrocytes from reprogrammed chondrocytes
#480METHOD FOR CRYOPRESERVATION OF CARDIOCYTES DERIVED FROM PLURIPOTENT STEM CELLS OR MESENCHYMAL STEM CELLS DERIVED FROM ADIPOSE TISSUE OR BONE MARROW
#481EXOSOME COMPOSITIONS AND METHODS FOR PREPARATION AND USE THEREOF FOR REGULATING AND CONDITIONING SKIN AND HAIR
#482MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS
#483EPIDERMAL NEURAL CREST STEM CELLS AS A SOURCE OF SCHWANN CELLS
#484Method of treating focal segmental glomerulosclerosis
#485INDUCTION OF HEPATOCYTES BY STEM CELL DIFFERENTIATION WITH RNA
#486Methods of treating neurodegenerative disorders
#487Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
#488MAPC treatment of brain injuries and diseases
#489HIGH-THROUGHPUT IMAGE-BASED CHEMICAL SCREENING IN ZEBRAFISH BLASTOMERE CELL CULTURE
#490Methods of generating oligodendrocytes and cell populations comprising same
#491DEVICE FOR INJECTING STEM CELLS
#492Methods of in vitro differentiation of midbrain dopamine (MPA) neurons
#493Method for inducing cerebral cortex neurons
#494Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
#495Iron platinum particles for adherence of biologics on medical implants
#496Mitochondrial epigenetic reprogramming and transplant
#497MARKERS FOR DIFFERENTIATION OF STEM CELLS INTO DIFFERENTIATED CELL POPULATIONS
#498RNA guided endonuclease targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same
#499Determining Stem Cell Treatment Effectiveness By Monitoring Physical Progress
#500Compositions and methods for prolonged cell storage
#501Methods to Accelerate Wound Healing in Diabetic Subjects
#502Bioengineered allogeneic blood vessel
#503Talen targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same
#504Methods of generating functional human tissue
#505MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#506Endonuclease targeting blood coagulation factor VIII gene and composition for treating hemophilia comprising same
#507Materials and methods for treatment of hemoglobinopathies
#508SOMATIC STEM CELLS
#509Induced hepatocytes and uses thereof
#510Cells expressing parathyroid hormone 1 receptor and uses thereof
#511Oligodendroglial cell culturing methods and in methods for treating neurodegenerative disorders by using thyroid hormones or analogues
#512Method for manufacturing ciliary margin stem cells
#513Compositions for regenerating defective or absent myocardium
#514Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage
#515Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
#516Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
#517ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#518Modified Cells Evoking Reduced Immunogenic Responses
#519Therapeutic Compositions and Methods
#520Use of des-aspartate-angiotensin I to treat patients exhibiting malignant growth, invasive growth, tumor, tumor metastasis or cancer
#521Tagged chimeric effector molecules and receptors thereof
#522INORGANICALLY SURFACE-MODIFIED POLYMERS AND METHODS FOR MAKING AND USING THEM
#523Method for the anti-senescence of and/or rejuvenating stem cells
#524IMPLANTABLE BIOREACTOR FOR DELIVERY OF PARACRINE FACTORS
#525Human pluripotent stem cell derived endocardial endothelium
#526METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL LINE FROM MESENCHYMAL STEM CELLS, AND CELL LINE OBTAINED THEREBY
#527Modulation of stem cells using zinc finger proteins
#528PLACENTAL STEM CELLS DERIVED FROM POST-PARTUM MAMMALIAN PLACENTA, AND USES AND METHODS OF TREATMENT USING SAID CELLS
#529WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
#530DERIVATION OF EMBRYONIC STEM CELLS
#531Methods for producing hormone secreting cells in a subject
#532METHODS USING REPROGRAMMED CELLS FOR REGENERATIVE, RESTORATIVE, AND REJUVENATIVE THERAPIES
#533Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#534Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#535TISSUE TRANSPLANT COMPOSITIONS AND METHODS FOR USE
#536Acellular bioabsorbable tissue regeneration matrices
#537METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
#538OPHTHALMIC DRUG DELIVERY METHOD
#539Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients
#540METHOD OF GENERATING MULTILINEAGE POTENTIAL CELLS FROM LYMPHOCYTES
#541IL-12 immunotherapy for cancer
#542GUIDING STEM CELL DIFFERENTIATION USING GRAPHENE-NANOFIBER HYBRID SCAFFOLDS
#543Albumin nanoparticles to augment stem cell function in vivo
#544Multilineage-differentiating stress enduring (MUSE) cells for treatment of chronic kidney disease
#545Pluripotent stem cell for treatment of cerebral infarction
#546Methods for treating age-related organ or tissue dysfunction through heterochronic transbiosis using nonviable pluripotent stem cells
#547Treatment of immune disorders
#548Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid
#549Methods for reprogramming cells and uses thereof
#550Methods for reprogramming cells and uses thereof
#551Lineage differentiation of encapsulated embryonic stem cells
#552Frozen therapeutic dose and package
#553Compounds that enhance Atoh1 expression
#554Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#555Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome
#556Personalized production of biologics and method for reprogramming somatic cells
#557COMBINED AUTOLOGOUS BIOLOGIC AND COLD THERAPY TREATMENT OF SKIN INJURIES
#558Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
#559SMALL ncRNAS AS BIOMARKERS
#560Compositions and methods for modulating stem cells and uses thereof
#561Method for treating or preventing a pancreatic dysfunction
#562Cadaveric derived wound treatment and method of use
#563Low oxygen tension enhances endothelial fate of human pluripotent stem cells
#564Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
#565Engineered adult-like human heart tissue
#566Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compounds
#567Ophthalmic drug delivery method
#568ALBUMIN NANOPARTICLES TO AUGMENT STEM CELL FUNCTION IN VIVO
#569Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage
#570Pluripotent cells
#571Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
#572PLACENTAL-DERIVED STEM CELLS AND USES THEREOF TO RESTORE THE REGENERATIVE ENGINE, CORRECT PROTEOMIC DEFECTS AND EXTEND LIFESPAN OF AGING SUBJECTS
#573Cardiac, mesenchymal and endothelial progenitor cell (CPC) chimeras and methods for making and using them
#574EPIGENETIC STEM CELL COMMITMENT-ASSOCIATED SIGNATURE
#575Methods for selective inhibition of pluripotent stem cells
#576Method for promoting generation of stem cell-derived exosome by using thrombin
#577Method for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, CXC chemokine receptor 4, and/or immune regulatory factor of stem cell
#578Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#579Tropic cell based virotherapy for the treatment of cancer
#580ADIPOSE TISSUE MESENCHYMAL STEM CELLS AND METHODS OF USE TO TREAT OR INHIBIT UTERINE DISORDERS
#581ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON'S DISEASE
#582Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells
#583Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient
#584Method for Producing Induced Pluripotent Stem Cells
#585Method of inducing differentiation of stem cell into corneal limbal stem cell
#586Method for enhancing therapeutic effect of stem cells
#587Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
#588Bone regeneration agent
#589Method for differentiating induced pluripotent stem cells into renal proximal tubular cell-like cells
#590Transduction buffer
#591Regenerative materials
#592Modulators of syndecan-2 and uses thereof
#593Compositions and methods for treating and preventing tissue injury and disease
#594Compositions comprising perivascular stem cells and nell-1 protein
#595METHOD OF PREPARING SOLUTION CONTAINING STEM CELLS
#596Method for producing retinal pigment epithelial cells
#597USES AND ISOLATION OF VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS
#598Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury
#599Therapeutic agent delivery system and method for arteries
#600Methods and compositions for treatment of penile defects